Drug Shortage Report for XYLOCARD
| Report ID | 222692 |
| Drug Identification Number | 00001937 |
| Brand name | XYLOCARD |
| Common or Proper name | lidocaine HCI 100mg 10x5mL SU Glass Ampoule |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 Ampoule |
| ATC code | C01BB |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-01 |
| Actual start date | |
| Estimated end date | 2024-09-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-03-18 |
| Company comments | VR44677CA1 XYLOCARD 20MG/ML AMP 10X5ML CA ASP |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-03-18 | French | Compare |
| v1 | 2024-03-18 | English | Compare |
Showing 1 to 2 of 2